Clinical Trials Logo
  1. Home
  2. Ascites
  3. NCT04550091
  4. Details
NCT04550091 Clinical Trial

Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites

Ascites Clinical Trial

Official title:
Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04550091
Other study ID # Hounsfields units
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 19, 2020
Est. completion date October 2022

Study information
Verified date September 2020
Source Assiut University
Contact merna yousef, resident
Phone 01020731292
Email Monna.merna13@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites

Description:

1. To detect accuracy of MDCT in differentiation between different types of ascites and its underlying cause .

2. To evaluate the diagnostic accuracy of measuring the CT density of the ascitic fluid (in Housefield units) to differentiate between different types of ascites in comparison to aspiration cytology results.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 88
Est. completion date October 2022
Est. primary completion date September 2022
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients who are diagnosed with ascites by clinical examination or by any other investigations such as ultrasound.

Exclusion Criteria:

- Patient with bleeding tendancy and on anticoagulant drugs.-

- Patients who are pregnant .

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Detection of ascites using CT
Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Outcome
Type Measure Description Time frame Safety issue
Primary differentiate between different types of ascites and its underlying cause differentiate between different types of ascites and its underlying causes by measuring the CT density of the ascitic fluid (in Hounsfield units) 2022
See also
  Status Clinical Trial Phase
Recruiting NCT02891642 - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Recruiting NCT00239096 - Prevention of Decompensation in Liver Cirrhosis Phase 4
Active, not recruiting NCT03973866 - Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) N/A
Terminated NCT01455246 - Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis Phase 2/Phase 3
Completed NCT01349348 - Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites Phase 3
Completed NCT01578226 - Procalcitonin in Cirrhotic Patients at High Risk for Sepsis N/A
Terminated NCT00548366 - Sodium Restriction in the Management of Cirrhotic Ascites Phase 4
Recruiting NCT05025878 - 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
Completed NCT03327688 - Point-of-care Ultrasound in Finland N/A
Not yet recruiting NCT01716611 - Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites Phase 4
Completed NCT01769040 - Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis Phase 4
Recruiting NCT05700708 - Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
Recruiting NCT05511766 - Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis Phase 2/Phase 3
Completed NCT05013502 - Empagliflozin in Diuretic Refractory Ascites Phase 1
Not yet recruiting NCT06436807 - PMCF Study of the CE-marked Drainova® ArgentiC Catheter
Completed NCT03263598 - Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites
Completed NCT00907673 - The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure N/A
Terminated NCT00796861 - Trial of Sunitinib for Refractory Malignant Ascites Phase 2
Suspended NCT00511394 - Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis N/A
Completed NCT04533854 - Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Analysis